Join
Live feed
·
PRReleasevia Quantisnow
Myovant Sciences Ltd. logo
Urovant Sciences Ltd. logo

Urovant Sciences Announces Publication in Blood Pressure Monitoring of Positive Ambulatory Blood Pressure Study Results for GEMTESA® (vibegron) 75 mg in Overactive Bladder Patients

ByQuantisnow·Wall Street's wire, on your screen.
MYOV· Myovant Sciences Ltd.UROV· Urovant Sciences Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MYOV (Myovant Sciences Ltd.), UROV (Urovant Sciences Ltd.) and more on Quantisnow.

Urovant Sciences Announces Publication in Blood Pressure Monitoring of Positive Ambulatory Blood Pressure Study Results for GEMTESA® (vibegron) 75 mg in Overactive Bladder Patients | Quantisnow